Monoclonal antibody
Type Whole antibody
Source Human
Target TSLP
Clinical data
ATC code none
CAS Number 1572943-04-4
ChemSpider none
Chemical and physical data
Formula C6400H9844N1732O1992S52
Molar mass 144.6 kDa

Tezepelumab (INN) is a human monoclonal antibody designed for the treatment of asthma and atopic dermatitis.[1][2]

This drug is being developed in collaboration by MedImmune, LLC and Amgen.


  1. Statement On A Nonproprietary Name Adopted By The USAN Council - Tezepelumab, American Medical Association.
  2. World Health Organization (2015). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 113" (PDF). WHO Drug Information. 29 (2).
This article is issued from Wikipedia - version of the 11/23/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.